“In April, an expert advisory panel for the FDA voted unanimously to recommend Epidiolex’s approval and determined that ‘CBD has a negligible abuse potential.’ The DEA did not immediately respond to Ars’ request for comment. But GW said it expects that the DEA will reschedule CBD within 90 days.”
Did you like this?
Tip Freedomwat.ch Staff with Bitcoin
Tip Freedomwat.ch Staff with Bitcoin
Related posts:
Western Media's Pravda-Like Lies on Syria Bombing
In Greece: As 'Austerity' Ignites Masses, Elites Turn To Imperial Stormtroopers
Shortages, warehouses and misinformation: Comex gold explained
Gold Stocks 101 (10 Gold Stocks Not To Own)
New Jersey woman busted for showing breasts, middle fingers to surveillance camera
Detroit Threatens To Remove Community-Provided Bus Stop Benches
New Zealand Regulates -- Not Bans -- Synthetic Drugs
U.S. Prison Population Seeing “Unprecedented Increase”
Social Media Now Being Used by Police, Intelligence to Collect Biometrics
Egypt invites Russia to mine uranium, build nuclear power plants
Alan Grayson on Syria strike: Military-industrial complex wants it, Americans don’t
Japanese Are Bailing Out of US Treasury Bonds
Someone built a meth lab inside a federal research facility, and it exploded
Short Video: Canadian Wait Times for Surgery; America’s Future
Boston’s Top Cop Warns Against “Police State”